NL1002937C2 - Gerede infusie-set. - Google Patents

Gerede infusie-set. Download PDF

Info

Publication number: NL1002937C2
Authority: NL; Netherlands
Prior art keywords: infusion; finished; infusion set; ready; set according
Prior art date: 1995-04-25

Application number

NL1002937A

Other languages

English (en)

Dutch (nl)

Other versions

NL1002937A1 (nl

Inventor

Michael Lobisch

Robert Hermann

Reinhard Muckenschnabel

Heinz Ulrich

Original Assignee

Asta Medica Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-04-25

Filing date

1996-04-24

Publication date

1998-12-22

1996-04-24 Application filed by Asta Medica Ag filed Critical Asta Medica Ag

1996-10-28 Publication of NL1002937A1 publication Critical patent/NL1002937A1/xx

1998-12-22 Application granted granted Critical

1998-12-22 Publication of NL1002937C2 publication Critical patent/NL1002937C2/nl

Links

238000001802 infusion Methods 0.000 title claims description 55
239000000243 solution Substances 0.000 claims description 19
AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 claims description 17
AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 claims description 17
235000019136 lipoic acid Nutrition 0.000 claims description 17
229960002663 thioctic acid Drugs 0.000 claims description 17
150000003839 salts Chemical class 0.000 claims description 9
239000007924 injection Substances 0.000 claims description 8
238000002347 injection Methods 0.000 claims description 8
239000000126 substance Substances 0.000 claims description 6
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 6
230000001681 protective effect Effects 0.000 claims description 5
229960000281 trometamol Drugs 0.000 claims description 4
239000003638 chemical reducing agent Substances 0.000 claims description 2
239000000644 isotonic solution Substances 0.000 claims description 2
239000000546 pharmaceutical excipient Substances 0.000 claims description 2
229910017053 inorganic salt Inorganic materials 0.000 claims 1
235000002639 sodium chloride Nutrition 0.000 description 12
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 11
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
239000011780 sodium chloride Substances 0.000 description 5
239000013543 active substance Substances 0.000 description 4
239000003978 infusion fluid Substances 0.000 description 4
239000011521 glass Substances 0.000 description 3
239000007788 liquid Substances 0.000 description 3
238000002560 therapeutic procedure Methods 0.000 description 3
241000894006 Bacteria Species 0.000 description 2
PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 2
238000005273 aeration Methods 0.000 description 2
238000010276 construction Methods 0.000 description 2
238000011109 contamination Methods 0.000 description 2
229940079593 drug Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000000463 material Substances 0.000 description 2
230000001954 sterilising effect Effects 0.000 description 2
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 1
241001631457 Cannula Species 0.000 description 1
208000032131 Diabetic Neuropathies Diseases 0.000 description 1
DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
206010040026 Sensory disturbance Diseases 0.000 description 1
239000002253 acid Substances 0.000 description 1
239000004480 active ingredient Substances 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
-1 alkali metal salts Chemical class 0.000 description 1
150000001413 amino acids Chemical class 0.000 description 1
239000003708 ampul Substances 0.000 description 1
230000000712 assembly Effects 0.000 description 1
238000000429 assembly Methods 0.000 description 1
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
201000002342 diabetic polyneuropathy Diseases 0.000 description 1
239000002552 dosage form Substances 0.000 description 1
230000008030 elimination Effects 0.000 description 1
238000003379 elimination reaction Methods 0.000 description 1
239000004615 ingredient Substances 0.000 description 1
238000003780 insertion Methods 0.000 description 1
230000037431 insertion Effects 0.000 description 1
230000007794 irritation Effects 0.000 description 1
230000003647 oxidation Effects 0.000 description 1
238000007254 oxidation reaction Methods 0.000 description 1
229910052760 oxygen Inorganic materials 0.000 description 1
239000001301 oxygen Substances 0.000 description 1
238000004806 packaging method and process Methods 0.000 description 1
238000007911 parenteral administration Methods 0.000 description 1
230000035945 sensitivity Effects 0.000 description 1
229910052708 sodium Inorganic materials 0.000 description 1
239000011734 sodium Substances 0.000 description 1
239000008354 sodium chloride injection Substances 0.000 description 1
239000007787 solid Substances 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
230000000087 stabilizing effect Effects 0.000 description 1
238000004659 sterilization and disinfection Methods 0.000 description 1
239000000725 suspension Substances 0.000 description 1
239000011573 trace mineral Substances 0.000 description 1
235000013619 trace mineral Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
239000002699 waste material Substances 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
239000008215 water for injection Substances 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Heart & Thoracic Surgery (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
Anesthesiology (AREA)
Engineering & Computer Science (AREA)
Vascular Medicine (AREA)
Chemical & Material Sciences (AREA)
Hematology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)
External Artificial Organs (AREA)
Medical Preparation Storing Or Oral Administration Devices (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NL1002937A 1995-04-25 1996-04-24 Gerede infusie-set. NL1002937C2 (nl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE29506604		1995-04-25
DE29506604U DE29506604U1 (de)	1995-04-25	1995-04-25	Fertiginfusionsset

Publications (2)

Publication Number	Publication Date
NL1002937A1 NL1002937A1 (nl)	1996-10-28
NL1002937C2 true NL1002937C2 (nl)	1998-12-22

Family

ID=8007014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NL1002937A NL1002937C2 (nl)	1995-04-25	1996-04-24	Gerede infusie-set.

Country Status (9)

Country	Link
AT (1)	AT1314U1 (de)
BE (1)	BE1009699A6 (de)
DE (1)	DE29506604U1 (de)
ES (1)	ES2125800B1 (de)
FR (1)	FR2733428B3 (de)
GB (1)	GB2300121B (de)
IT (2)	ITTO960094U3 (de)
NL (1)	NL1002937C2 (de)
PT (2)	PT9273T (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN110296811A (zh) *	2019-07-03	2019-10-01	湖南科技大学	一种雷诺实验装置颜色水流量两级调节装置
CN113197845A (zh) *	2020-12-16	2021-08-03	南京海融制药有限公司	一种硫辛酸氨丁三醇注射液及其制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4534758A (en) *	1983-07-15	1985-08-13	Eli Lilly & Company	Controlled release infusion system
EP0318891A1 (de) *	1987-12-04	1989-06-07	ASTA Medica Aktiengesellschaft	Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1145307B (de) *	1958-11-21	1963-03-14	Galasyn Inc	Geraet fuer intravenoese Dauertropfinfusionen
DE2740811A1 (de) *	1976-09-14	1978-03-16	Sheldon S Zelitt	Parenterales anwendungsgeraet fuer intravenoese infusionen
US4248223A (en) *	1978-03-20	1981-02-03	Turner Charles R	Self-priming parenteral administering apparatus
US4192306A (en) *	1978-08-21	1980-03-11	Abbott Laboratories	Catheter placement assembly having axial and rotational alignment means
US4236515A (en) *	1979-02-28	1980-12-02	Abbott Laboratories	Equipment sets and system for the sequential administration of medical liquids at dual flow rates employing parallel secondary liquid tubing
ES2026058A6 (es) *	1990-10-26	1992-04-01	Parreno Rey Antonio	Sistema para infusion parenteral con recambio automatico de frasco.
DE9213914U1 (de) *	1992-10-15	1992-12-03	Asta Medica AG, 6000 Frankfurt	Ampulle und Infusionslösung von Thioctsäure in Form der wasserlöslichen Salze der Thioctsäure

1995
- 1995-04-25 DE DE29506604U patent/DE29506604U1/de not_active Expired - Lifetime
1996
- 1996-04-19 GB GB9608214A patent/GB2300121B/en not_active Expired - Lifetime
- 1996-04-23 PT PT9273U patent/PT9273T/pt active IP Right Grant
- 1996-04-24 AT AT0023796U patent/AT1314U1/de not_active IP Right Cessation
- 1996-04-24 IT IT96TO000094U patent/ITTO960094U3/it unknown
- 1996-04-24 BE BE9600359A patent/BE1009699A6/fr not_active IP Right Cessation
- 1996-04-24 NL NL1002937A patent/NL1002937C2/nl not_active IP Right Cessation
- 1996-04-24 ES ES09600928A patent/ES2125800B1/es not_active Expired - Fee Related
- 1996-04-24 FR FR9605172A patent/FR2733428B3/fr not_active Expired - Lifetime
- 1996-04-24 IT IT96TO000331A patent/IT1285056B1/it active IP Right Grant
1997
- 1997-10-21 PT PT102071A patent/PT102071B/pt active IP Right Grant

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4534758A (en) *	1983-07-15	1985-08-13	Eli Lilly & Company	Controlled release infusion system
EP0318891A1 (de) *	1987-12-04	1989-06-07	ASTA Medica Aktiengesellschaft	Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren

Also Published As

Publication number	Publication date
GB9608214D0 (en)	1996-06-26
GB2300121B (en)	1998-12-23
FR2733428A1 (fr)	1996-10-31
IT1285056B1 (it)	1998-06-03
ITTO960331A1 (it)	1997-10-24
GB2300121A (en)	1996-10-30
PT102071A (pt)	1998-07-31
PT9273T (pt)	1997-06-30
ITTO960331A0 (it)	1996-04-24
ES2125800A1 (es)	1999-03-01
DE29506604U1 (de)	1995-06-14
AT1314U1 (de)	1997-03-25
PT102071B (pt)	1999-09-30
ITTO960331A3 (it)	1997-10-24
NL1002937A1 (nl)	1996-10-28
FR2733428B3 (fr)	1997-06-13
ES2125800B1 (es)	1999-10-01
ITTO960094U3 (it)	1997-10-24
BE1009699A6 (fr)	1997-07-01
ITTO960094V0 (it)	1996-04-24

Legal Events

Date	Code	Title	Description
1997-01-06	AD1A	A request for search or an international type search has been filed
1998-12-01	RD2N	Patents in respect of which a decision has been taken or a report has been made (novelty report)	Effective date: 19981019
1999-03-01	PD2B	A search report has been drawn up
2002-12-02	SD	Assignments of patents	Owner name: VIATRIS GMBH & CO. KG
2007-05-01	TD	Modifications of names of proprietors of patents	Owner name: MEDA PHARMA GMBH & CO. KG Effective date: 20070308
2016-04-28	MK	Patent expired because of reaching the maximum lifetime of a patent	Effective date: 20160423

Publication	Publication Date	Title
ES2223549T3 (es)	2005-03-01	Formulacion que contiene moxifloxacino y sal comun.
US12083087B2 (en)	2024-09-10	Aqueous formulation comprising paracetamol and ibuprofen
KR100889090B1 (ko)	2009-03-17	에스몰올 제제
RU97104030A (ru)	1999-05-10	Фармацевтически стабильный препарат оксалиплатины
US11116696B2 (en)	2021-09-14	Reconstitution device, system, and method to administer a drug in a moderate bolus
EA008308B1 (ru)	2007-04-27	Жидкие стабилизированные белковые составы в фармацевтических контейнерах с покрытием
RU2286774C2 (ru)	2006-11-10	Препарат эсмолола
NL1002937C2 (nl)	1998-12-22	Gerede infusie-set.
EP2659902A1 (de)	2013-11-06	Leuprolidinjektion
KR20100022068A (ko)	2010-02-26	농축 에스몰올
US11147926B2 (en)	2021-10-19	Intrathecal baclofen pharmaceutical dosage forms and related delivery system
EP2846776B1 (de)	2020-04-15	Parenterale esmololformulierung
US6545039B1 (en)	2003-04-08	Facilitated administration of α-lipoic acid or derivatives thereof
AU2008256949B2 (en)	2013-02-07	Multi-dose concentrate esmolol with benzyl alcohol
EP3345592A1 (de)	2018-07-11	Ketorolacformulierungen mit erweiterter stabilität sowie verfahren und vorrichtungen zur verwendung damit
Chapman	2004	Parenteral products
AU2014203121B2 (en)	2016-04-21	Concentrate esmolol
HK1204265B (en)	2020-12-24	Parenteral esmolol formulation